{"id":"https://openalex.org/W7204690948","doi":"https://doi.org/10.1016/s2152-2650(26)02995-2","title":"MM-1168: Belantamab Mafodotin, Bortezomib, and Dexamethasone vs Daratumumab, Bortezomib, and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Updated 4-Year Results of the Phase 3 DREAMM-7 Trial","display_name":"MM-1168: Belantamab Mafodotin, Bortezomib, and Dexamethasone vs Daratumumab, Bortezomib, and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Updated 4-Year Results of the Phase 3 DREAMM-7 Trial","publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7204690948","doi":"https://doi.org/10.1016/s2152-2650(26)02995-2"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(26)02995-2","doi":"https://doi.org/10.1016/s2152-2650(26)02995-2","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)02995-2","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043351209","display_name":"Robert M. Rifkin","orcid":"https://orcid.org/0000-0003-3141-1518","observed_orcids":["https://orcid.org/0000-0003-3141-1518"]},"institutions":[{"id":"https://openalex.org/I4210087413","display_name":"University of Colorado Health","ror":"https://ror.org/0107w4315","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087413"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Rifkin","raw_affiliation_strings":["UCHealth Jan Bishop Cancer Center, Steamboat Springs, CO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCHealth Jan Bishop Cancer Center, Steamboat Springs, CO, USA","institution_ids":["https://openalex.org/I4210087413"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113348821","display_name":"V\u00e2nia Hungria","orcid":"https://orcid.org/0000-0002-4327-1957","observed_orcids":["https://orcid.org/0000-0002-4327-1957"]},"institutions":[{"id":"https://openalex.org/I4210112463","display_name":"S\u00e3o Germano Oncologia","ror":"https://ror.org/01dh8xz10","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210112463"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Vania Hungria","raw_affiliation_strings":["Clinica S\u00e3o Germano, S\u00e3o Paulo, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinica S\u00e3o Germano, S\u00e3o Paulo, Brazil","institution_ids":["https://openalex.org/I4210112463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033354752","display_name":"Marek Hus","orcid":"https://orcid.org/0000-0002-9036-6625","observed_orcids":["https://orcid.org/0000-0002-9036-6625"]},"institutions":[{"id":"https://openalex.org/I121032520","display_name":"Medical University of Lublin","ror":"https://ror.org/016f61126","country_code":"PL","type":"education","lineage":["https://openalex.org/I121032520"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Marek Hus","raw_affiliation_strings":["Medical University of Lublin, Lublin, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of Lublin, Lublin, Poland","institution_ids":["https://openalex.org/I121032520"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040499157","display_name":"\u0416\u0435\u0440\u0435\u0431\u0446\u043e\u0432\u0430 \u0412\u0435\u0440\u0430 \u0410\u043d\u0430\u0442\u043e\u043b\u044c\u0435\u0432\u043d\u0430","orcid":"https://orcid.org/0000-0002-3052-269X","observed_orcids":["https://orcid.org/0000-0002-3052-269X"]},"institutions":[{"id":"https://openalex.org/I4210121251","display_name":"Botkin Hospital","ror":"https://ror.org/01xbp4f63","country_code":"RU","type":"healthcare","lineage":["https://openalex.org/I4210121251"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Vera Zherebtsova","raw_affiliation_strings":["Gorodskaya Klinicheskaya Bol'nitsa Im. S.p. Botkina, Moscow, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gorodskaya Klinicheskaya Bol'nitsa Im. S.p. Botkina, Moscow, Russian Federation","institution_ids":["https://openalex.org/I4210121251"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148695623","display_name":"Christopher Ward","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800079252","display_name":"Royal North Shore Hospital","ror":"https://ror.org/02gs2e959","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800079252"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Christopher Ward","raw_affiliation_strings":["Royal North Shore Hospital, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal North Shore Hospital, Sydney, Australia","institution_ids":["https://openalex.org/I2800079252"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009395461","display_name":"Phoebe Joy Ho","orcid":"https://orcid.org/0000-0002-2811-8671","observed_orcids":["https://orcid.org/0000-0002-2811-8671"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2799732068","display_name":"Royal Prince Alfred Hospital","ror":"https://ror.org/05gpvde20","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799732068"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"P Joy Ho","raw_affiliation_strings":["Royal Prince Alfred Hospital, and University of Sydney, Camperdown, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Prince Alfred Hospital, and University of Sydney, Camperdown, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2799732068"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024217548","display_name":"\u00c2ngelo Maiolino","orcid":"https://orcid.org/0000-0003-0140-9548","observed_orcids":["https://orcid.org/0000-0003-0140-9548"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angelo Maiolino","raw_affiliation_strings":["Instituto Am\u00e9ricas, Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Am\u00e9ricas, Rio de Janeiro, Brazil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148619595","display_name":"Roman H\u00e1jek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I187293425","display_name":"University of Ostrava","ror":"https://ror.org/00pyqav47","country_code":"CZ","type":"education","lineage":["https://openalex.org/I187293425"]},{"id":"https://openalex.org/I4210088935","display_name":"University Hospital Ostrava","ror":"https://ror.org/00a6yph09","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210088935"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Roman H\u00e1jek","raw_affiliation_strings":["Department of Hematooncology, University Hospital Ostrava, Ostrava and Department of Hematooncology, University of Ostrava, Ostrava, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematooncology, University Hospital Ostrava, Ostrava and Department of Hematooncology, University of Ostrava, Ostrava, Czech Republic","institution_ids":["https://openalex.org/I187293425","https://openalex.org/I4210088935"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100353399","display_name":"Kihyun K\u0131m","orcid":"https://orcid.org/0000-0002-5878-8895","observed_orcids":["https://orcid.org/0000-0002-5878-8895"]},"institutions":[{"id":"https://openalex.org/I2802194831","display_name":"Samsung Medical Center","ror":"https://ror.org/05a15z872","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2250650973","https://openalex.org/I2802194831"]},{"id":"https://openalex.org/I848706","display_name":"Sungkyunkwan University","ror":"https://ror.org/04q78tk20","country_code":"KR","type":"education","lineage":["https://openalex.org/I848706"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Kihyun Kim","raw_affiliation_strings":["Sungkyunkwan University, Samsung Medical Center, Seoul, Korea, Republic of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sungkyunkwan University, Samsung Medical Center, Seoul, Korea, Republic of","institution_ids":["https://openalex.org/I2802194831","https://openalex.org/I848706"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088943742","display_name":"Hanlon Sia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hanlon Sia","raw_affiliation_strings":["Pindara Private Hospital, Gold Coast, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pindara Private Hospital, Gold Coast, Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5130335866","display_name":"Adam Bryant","orcid":"https://orcid.org/0009-0000-1621-4327","observed_orcids":["https://orcid.org/0009-0000-1621-4327"]},"institutions":[{"id":"https://openalex.org/I2800849109","display_name":"Liverpool Hospital","ror":"https://ror.org/03zzzks34","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800849109"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Adam Bryant","raw_affiliation_strings":["Liverpool Hospital, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Liverpool Hospital, Sydney, Australia","institution_ids":["https://openalex.org/I2800849109"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084502515","display_name":"Marcelo Pitombeira de Lacerda","orcid":"https://orcid.org/0000-0001-5554-7167","observed_orcids":["https://orcid.org/0000-0001-5554-7167"]},"institutions":[{"id":"https://openalex.org/I4210100389","display_name":"Universidade da Regi\u00e3o de Joinville","ror":"https://ror.org/00je1p681","country_code":"BR","type":"education","lineage":["https://openalex.org/I4210100389"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Marcelo Pitombeira de Lacerda","raw_affiliation_strings":["Universidade da Regi\u00e3o de Joinville and Centro de Hematologia e Oncologia, Joinville, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidade da Regi\u00e3o de Joinville and Centro de Hematologia e Oncologia, Joinville, Brazil","institution_ids":["https://openalex.org/I4210100389"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077430940","display_name":"Anna Maria Sureda","orcid":"https://orcid.org/0000-0002-1238-6970","observed_orcids":["https://orcid.org/0000-0002-1238-6970"]},"institutions":[{"id":"https://openalex.org/I4210087039","display_name":"Institut d'Investigaci\u00f3 Biom\u00e9dica de Bellvitge","ror":"https://ror.org/0008xqs48","country_code":"ES","type":"facility","lineage":["https://openalex.org/I157913058","https://openalex.org/I2802050225","https://openalex.org/I4210087039","https://openalex.org/I4210096656","https://openalex.org/I4210106543","https://openalex.org/I4210107147","https://openalex.org/I4210153292","https://openalex.org/I4387153040","https://openalex.org/I71999127"]},{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Anna Sureda","raw_affiliation_strings":["Clinical Hematology Department, Institut Catal\u00e0 d\u2019Oncologia - L\u2019Hospitalet, Institut de Ci\u00e8ncies Biom\u00e8diques de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Hematology Department, Institut Catal\u00e0 d\u2019Oncologia - L\u2019Hospitalet, Institut de Ci\u00e8ncies Biom\u00e8diques de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I4210087039","https://openalex.org/I4210107147","https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020620994","display_name":"Benga Kazeem","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Benga Kazeem","raw_affiliation_strings":["GSK, Stevenage, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Stevenage, United Kingdom","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113236473","display_name":"Hena Baig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126541","display_name":"GlaxoSmithKline (Canada)","ror":"https://ror.org/02zz8mw60","country_code":"CA","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210126541"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Hena Baig","raw_affiliation_strings":["GSK, Mississauga, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Mississauga, Canada","institution_ids":["https://openalex.org/I4210126541"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025863797","display_name":"Nick Pirooz","orcid":"https://orcid.org/0009-0006-4371-534X","observed_orcids":["https://orcid.org/0009-0006-4371-534X"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nick Pirooz","raw_affiliation_strings":["GSK, Collegeville, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Collegeville, PA, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147068779","display_name":"Sybil Varghese","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sybil Varghese","raw_affiliation_strings":["GSK, Collegeville, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Collegeville, PA, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148646566","display_name":"Joe Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Joe Lee","raw_affiliation_strings":["GSK, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, London, United Kingdom","institution_ids":["https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5139445145","display_name":"Tom Jiang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tom Jiang","raw_affiliation_strings":["GSK, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, New York, NY, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017586611","display_name":"Pawel J. Robak","orcid":"https://orcid.org/0000-0002-6078-5415","observed_orcids":["https://orcid.org/0000-0002-6078-5415"]},"institutions":[{"id":"https://openalex.org/I4210122071","display_name":"Medical University of Lodz","ror":"https://ror.org/02t4ekc95","country_code":"PL","type":"education","lineage":["https://openalex.org/I4210122071"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Pawe\u0142 Robak","raw_affiliation_strings":["Medical University of \u0141\u00f3d\u017a, \u0141\u00f3d\u017a, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of \u0141\u00f3d\u017a, \u0141\u00f3d\u017a, Poland","institution_ids":["https://openalex.org/I4210122071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029159537","display_name":"Mar\u00eda\u2010Victoria Mateos","orcid":"https://orcid.org/0000-0003-2390-1218","observed_orcids":["https://orcid.org/0000-0003-2390-1218"]},"institutions":[{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]},{"id":"https://openalex.org/I4210134045","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","ror":"https://ror.org/03em6xj44","country_code":"ES","type":"facility","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034","https://openalex.org/I4210134045"]},{"id":"https://openalex.org/I4210138819","display_name":"Centro de Investigaci\u00f3n del C\u00e1ncer","ror":"https://ror.org/04rxrdv16","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4210138819"]},{"id":"https://openalex.org/I4388891778","display_name":"Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer de Salamanca","ror":"https://ror.org/043vr8e29","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4388891778"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Mar\u00eda-Victoria Mateos","raw_affiliation_strings":["Hematology Department, University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Department, University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain","institution_ids":["https://openalex.org/I184999862","https://openalex.org/I4210134045","https://openalex.org/I4210138819","https://openalex.org/I4388891778"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030746256","display_name":"Al-Ola A. Abdallah","orcid":"https://orcid.org/0000-0002-6603-185X","observed_orcids":["https://orcid.org/0000-0002-6603-185X"]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Al-Ola Abdallah","raw_affiliation_strings":["University of Kansas Medical Center, Kansas City, KS, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kansas Medical Center, Kansas City, KS, USA","institution_ids":["https://openalex.org/I4210128618"]}]}],"institutions":[],"countries_distinct_count":10,"institutions_distinct_count":26,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":null,"first_page":"S1151","last_page":"S1152"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/relapsed-refractory-multiple-myeloma","display_name":"relapsed/refractory multiple myeloma","score":0.9739999771118164},{"id":"https://openalex.org/keywords/belantamab-mafodotin","display_name":"belantamab mafodotin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/daratumumab","display_name":"daratumumab","score":0.9649999737739563},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.8840000033378601},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.996999979019165},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6380000114440918},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":1.0},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.6430000066757202}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9639000296592712},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.7390999794006348},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4237000048160553},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4194999933242798},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.3474999964237213},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.31630000472068787},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.30320000648498535},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.2856000065803528},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.2102999985218048},{"id":"https://openalex.org/C2777334693","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Maximum tolerated dose","level":3,"score":0.20229999721050262}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(26)02995-2","doi":"https://doi.org/10.1016/s2152-2650(26)02995-2","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)02995-2","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4412461073","https://openalex.org/W4391559535","https://openalex.org/W4405043193","https://openalex.org/W3095662656","https://openalex.org/W7108604932","https://openalex.org/W4392284807","https://openalex.org/W4399480854","https://openalex.org/W4413781006","https://openalex.org/W4410810137","https://openalex.org/W4405052520"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-08-31T00:00:00"}